This course is still available as a learning tool but has expired for CME credit.
The 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) 2013 was very dynamic during this exciting era of newer pharmacotherapies to manage patients with hepatitis C. Nancy Reau, MD has reviewed and selected the major clinical trial data presented at AASLD 2013 to develop this comprehensive CME Medical Meeting Reporter. This venue covered important information concerning the screening and diagnosis of the baby boomer generation, therapeutic choices across all genotypes, as well as data concerning patients with cirrhosis and advanced liver dysfunction. This Medical Meeting Reporter will assist the already busy hepatologist/clinician in navigating complex clinical decisions for patients with hepatitis C and advising primary care peers on the application of newer therapies.
This activity was designed to meet the needs of hepatologists, infectious diseases specialists, gastroenterologists, primary care practitioners, and other healthcare professionals who care for patients with hepatitis C virus (HCV).
- Implement appropriate screening, diagnosis, and initial treatment into practice
- Analyze emergent clinical trial data in HCV